Brain stimulation for depression
Transcranial magnetic stimulation, including accelerated theta-burst protocols, for depression.
Key point
Connectivity- or frequency- and connectivity-individualized accelerated iTBS failed to yield significant antidepressant benefits over sham stimulation in treatment-resistant depression.
From: Connectivity- and frequency-individualized accelerated intermittent theta burst stimulation in treatment-resistant depression: A randomized controlled trial (J Affect Disord, 2026 Dec 15) ↗Papers per year
Each bar is 12 months; the last one ends 17 Oct 2026. New trials in the same years: 0, 0, 0, 0, 0.
All papers from the last 12 months
613 papers (18 Oct 2025 – 17 Oct 2026), newest first. Loading the full list…
- Predicting remission following repetitive transcranial magnetic stimulation in treatment-resistant depression: a comparison of parsimonious and ensemble machine learning modelsJ Affect Disord2027 Jan 1PMID 42849857
- Connectivity- and frequency-individualized accelerated intermittent theta burst stimulation in treatment-resistant depression: A randomized controlled trialJ Affect Disord2026 Dec 15PMID 42749167RCT
- Efficacy of tDCS-primed iTBS in major depressive disorder: A randomized, sham-controlled trial with exploratory resting motor threshold analysesJ Affect Disord2026 Dec 15PMID 42727730RCT
- Right DLPFC repetitive transcranial magnetic stimulation in women with borderline personality disorder: A double-blind randomized sham-controlled trialJ Affect Disord2026 Dec 15PMID 42697251RCT
- Sustaining the therapeutic effect of rTMS treatment through maintenance: A naturalistic studyJ Affect Disord2026 Dec 15PMID 42674300
- Intermittent theta-burst stimulation versus sham stimulation for suicidal ideation and psychiatric symptoms in depressive disorders: A systematic review and meta-analysis of randomized controlled trialsPCN Rep2026 DecPMID 42872127Review
- Dose effect of bilateral transcranial magnetic stimulation for depression and anxiety in a real-world clinical settingJ Mood Anxiety Disord2026 DecPMID 42835941
- Protocol for a prospective, single-arm pilot trial assessing the clinical and supraspinal neural effects of non-invasive transcranial neuromodulation in adults with overactive bladderContemp Clin Trials Commun2026 DecPMID 42781031
- The effects of deep TMS on QEEG power, asymmetry, and coherence metrics in major depressive disorderPsychiatry Res2026 DecPMID 42700487
- Comparative efficacy of interventions for transdiagnostic anhedonia: a network meta-analysisPsychiatry Res2026 DecPMID 42700486
More psychiatry trends
All specialties →Loneliness and health
Loneliness and social isolation as risk factors.
Gut microbiome and mental health
Links between the gut microbiome and depression or anxiety.
Psilocybin therapy
Psilocybin-assisted therapy for depression and other conditions.
MDMA-assisted therapy
MDMA combined with psychotherapy, mainly studied in PTSD.
Ketamine and esketamine for depression
Ketamine and esketamine for treatment-resistant depression.
Muscarinic antipsychotics
Xanomeline-trospium and other muscarinic drugs for schizophrenia.
Too many papers to read?
PubDaily picks the ones that matter in your specialty and summarises them, about 10 minutes a week.
How these numbers are counted
PubMed query, searched in titles and abstracts by publication date:
("transcranial magnetic stimulation"[tiab] OR TMS[tiab] OR "theta burst"[tiab]) AND depress*[tiab]Trials: ClinicalTrials.gov studies first submitted in each 12-month window that match the same terms. A query can miss synonyms or catch unrelated papers, so treat counts as approximate.